10.6084/m9.figshare.c.3615500_D1.v1
Maud Marques
Maud
Marques
Marie-Claude Beauchamp
Marie-Claude
Beauchamp
Hubert Fleury
Hubert
Fleury
Ido Laskov
Ido
Laskov
Sun Qiang
Sun
Qiang
Manuela Pelmus
Manuela
Pelmus
Diane Provencher
Diane
Provencher
Anne-Marie Mes-Masson
Anne-Marie
Mes-Masson
Walter Gotlieb
Walter
Gotlieb
Michael Witcher
Michael
Witcher
Additional file 1: Figure S1. of Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors
Springer Nature
2015
Chemotherapy
PARP inhibitors
PARP1
ovarian cancer
2015-09-09 05:00:00
Figure
https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Chemotherapy_reduces_PARP1_in_cancers_of_the_ovary_implications_for_future_clinical_trials_involving_PARP_inhibitors/4376582
PARP1 antibody validation. (A) Western blot of PARP1 and actin were performed on OVCAR8 cells infected with shRNA control or directed against PARP1. (B) The same cells used in (A) were paraffin-embedded and IHC staining against PARP1 was performed using the same antibody as in (A). The antibody shows high specificity and sensitivity for PARP1 protein in both techniques. (TIFF 1130Â kb)